𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effectiveness of CMV prophylaxis in donor positive recipient negative (D+/R)-liver transplant recipients

✍ Scribed by Alajmi, Misfer A.; Gregor, Jamie C.; Marotta, Paul J.

Book ID
123230141
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
182 KB
Volume
118
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au